Inclusion of Acitretin into Cyclodextrins: Phase Solubility, Photostability, and Physicochemical Characterization

Journal of Pharmaceutical Sciences

Volumn 92, Issue 12, 2003, Pages 2449-2457

  Liu, Xin ^a   Lin, Hai Shu ^a   Thenmozhiyal, J C ^a   Chan, Sui Yung ^a   Ho, Paul C ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

Acitretin; Complexation; Cyclodextrins; Physical characterization; Solubility; Stability

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ETRETIN; METHYL BETA CYCLODEXTRIN;

AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DEGRADATION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STRUCTURE; INFRARED SPECTROSCOPY; LIGHT EXPOSURE; MOLECULAR MODEL; PH; PHYSICAL CHEMISTRY; X RAY DIFFRACTION;

EID: 0344443702     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10495     Document Type: Article

References (28)

1. Pilkington T, Brogden NR. 1992. Acitretin: A review of its pharmacology and therapeutic use. Drugs 43:597-627.
2. Christos CZ. 2001. Retinoids - Which dermatological indications will benefit in the near future? Skin Pharmacol Appl Skin Physiol 14:303-315.
3. Orfanos EC, Zouboulis CC, Almond-Roesler B, Geilen CC. 1997. Current use and future potential role of retinoids in dermatology. Drugs 53:358-388.
4. Paravieini U. 1981. On the metabolism and pharmacokinetics of an oral aromatic retinoid. Ann NY Acad Sci 395:54-57.
5. Masserella J, Vane F, Bugge C, Rodriguez L, Cunningham WJ, Franz T, Colburn W. 1985. Etretinate kinetics during chronic dosing in severe psoriasis. Clin Pharmacol Ther 37:439-446.
6. Wiegand UW, Chou RC. 1998. Pharmacokinetics of acitretin and etretinate. J Am Acad Dermatol 39:S25-S33.
7. Loftsson T, Sigurardottir MA, Olafsson HJ. 1995. Improved acitretin delivery through hairless mouse skin by cyclodextrin complexation. Int J Pharm 115:255-258.
8. Lehman PA, Slattery JT, Franz TJ. 1988. Percutaneous absorption of retinoids: Influence of vehicle, light exposure, and dose. J Invest Dermatol 91:56-61.
9. McNamara JP, Jewell CR, Jensen KB, Brindley JC. 1988. Food increases the bioavailabilty of acitretin. J Clin Pharmacol 28:1051-1055.
10. Loftsson T, Brewster EM. 1996. Pharmaceutical applications of cyclodextrins 1. Drug solubilization and stabilization. J Pharm Sci 85:1017-1025.
11. Moster G, Thompson D. Complexation and cyclodextrins. Encyclopedia of Pharmaceutical Technology, Vol. 19. New York: Marcel Dekker, Inc., pp 49-88.
12. Frank DW, Gray JE, Weaver RN. 1976. Cyclodextrin nephrosis in the rat. Am J Pathol 83:367-382.
13. Rajewski AR, Stella VJ. 1996. Pharmaceutical applications of cyclodextrins 2. In vivo delivery. J Pharm Sci 85:1142-1169.
14. Stella VJ, Rajewski AR. 1997. Cyclodextrins: Their future in drug formulation and delivery. Pharm Res 14:556-567.
15. Lin HS, Chean CS, Ng YY, Chan SY, Ho PC. 2000. 2-Hydroxypropyl-β -cyclodextrin increases aqueous solubility and photostability of all-trans-retinoic acid. J Clin Pharm Ther 25:265-269.
16. Higuchi T, Connors KA. 1965. Phase-solubility techniques. Adv Anal Chem Instruments 4:117-212.
17. Tinwalla AY, Hoesterey BL, Xiang TX, Lim K, Anderson B. 1993. Solubilization of thiazolobenzimidazole using a combination of pH adjustment and complexation with 2-hydroxypropyl-β-cyclodextrin. Pharm Res 10:1136-1143.
18. Okimoto K, Rajewski RA, Uekama K, Jona JA, Stella VJ. 1996. The interaction of charged and uncharged drugs with neutral (HP-β-CD) and anionically charged (SBE7-β-CD) β-cyclodextrins. Pharm Res 13:256-264.
19. Brewster ME, Loftsson T, Estes KS, Lin JL, Frideiksdottir H, Bodor N. 1992. Effect of various cyclodextrins on solution stability and dissolution rate of doxorubicin hydrochloride. Int J Pharm 79:289-299.
20. Erden N, Celebi N. 1988. A study of the inclusion complex of naproxen with β-cyclodextrin. Int J Pharm 48:83-89.
21. Mura P, Bettinetti G, Melani F, Manderioli A. 1995. Interaction between naproxen and chemically modified β-cyclodextrins in the liquid and solid state. Eur J Pharm Sci 3:347-355.
22. Uekama K, Otagiri M. 1987. Cyclodextrins in drug carrier systems. Crit Rev Ther Drug Carrier Syst 3:1-40.
23. Liu RSH, Asato AE. 1984. Photochemistry and synthesis of stereoisomers of vitamin A. Tetrahedron 40:1931-1969.
24. Berne B, Rollman O, Vahlquist A. 1990. UV-induced isomerization of oral retinoids in vitro and in vivo in hairless mice. Photodermato Photoimmuno Photomed 7:146-152.
25. st International Symposium on Cyclodextrins, Budapest, Hungary; pp 237-243.
26. Magis NLJ, Blummel JJH, Van de Kerkhof PCM, Gerritsen RMJP. 2002. The treatment of psoriasis with etretinate and acitretin: A follow up of actual use. Eur J Dermatol 10:517-521.
27. Lin HS, Chan SY, Low KSY, Shoon ML, Ho PC. 2000. Kinetic study of a 2-hydroxypropyl-beta-cyclodextrin-based formulation of all-trans-retinoic acid in Sprague-Dawley rats after oral or intravenous administration. J Pharm Sci 89:260-267.
28. Lin HS, Barua AB, Olson JA, Low KSY, Chan SY, Shoon ML, Ho PC. 2001. Pharmacokinetic study of all-trans-retinoyl-beta-D-glucuronide in Sprague-Dawley rats after single and multiple intravenous administration(s). J Pharm Sci 90:2023-2031.